Click here to close now.


SYS-CON UK Authors: Salvatore Genovese, Jamie Matusow

News Feed Item

Array BioPharma to Present at the Lazard Annual Healthcare and Jefferies 2012 Global Healthcare Conferences

BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the following upcoming conferences.  The public is welcome to participate in the conferences through webcasts on the Array BioPharma website:   




Lazard Capital Markets 9th Annual Healthcare Conference


Tuesday, November 13, 2012


11:00 a.m. Eastern Time


The Pierre Hotel, New York, NY


Jefferies 2012 Global Healthcare Conference


Thursday, November 15, 2012


2:20 p.m.  Greenwich Mean Time


London, England

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013.  For more information on Array, please go to

CONTACT: Tricia Haugeto 
Array BioPharma Inc.

SOURCE Array BioPharma Inc.

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.